Fatal Tumor Lysis Syndrome During Chemotherapy in Small Cell Lung Cancer / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
; : 215-218, 2008.
Article
in Ko
| WPRIM
| ID: wpr-77098
Responsible library:
WPRO
ABSTRACT
Tumor lysis syndrome is a life-threatening complication of anti-cancer therapy that typically occurs in patients with large, rapidly growing and treatment-sensitive tumors such as high-grade lymphomas and acute leukemias. However, its incidence in solid tumors has been known to be very low. Tumor lysis syndrome in solid tumors has a high mortality rate owing to the lack of prophylactic therapy to prevent this complication. We report a case of fatal tumor lysis syndrome developed during chemotherapy in extensive-stage small cell lung cancer, along with a brief review of the relevant literature considering the rarity of this manifestation in solid tumor.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Lymphoma, Non-Hodgkin
/
Tumor Lysis Syndrome
/
Leukemia
/
Incidence
/
Small Cell Lung Carcinoma
Type of study:
Incidence_studies
/
Prognostic_studies
Limits:
Humans
Language:
Ko
Journal:
Tuberculosis and Respiratory Diseases
Year:
2008
Type:
Article